News about Drug Discovery & Development

Anixa Biosciences Signs JDA with Cleveland Clinic to Develop Novel Vaccines for Various Cancer Types

The vaccines focus on a novel scientific mechanism never used before in a cancer vaccine.

Drug Discovery & Development | 08/05/2024 | By Manvi |  431

Selvita Acquires PozLab to Expand its Drug Development Capabilities

Selvita has completed a strategic transaction in which it has acquired 100% of shares in PozLab.

Drug Discovery & Development | 08/05/2024 | By Aishwarya |  531

ARTBIO and Nucleus to Manufacture GMP-Grade Therapeutic Products

ARTBIO, Inc. has announced a strategic manufacturing and supply agreement with Nucleus RadioPharma Inc. to support ARTBIO’s therapeutic product manufacturing.

Drug Discovery & Development | 08/05/2024 | By Aishwarya |  433

Gossamer Bio Partners with Chiesi to Develop and Commercialize Seralutinib

Gossamer Bio, Inc. has signed a global collaboration and license deal with Chiesi Farmaceutici to develop and commercialize seralutinib.

Drug Discovery & Development | 07/05/2024 | By Aishwarya |  386

Vesica Health Announces Launch of AssureMDx Test to Improve Bladder Cancer Detection

VESICA HEALTH, INC., a multi-omics liquid biopsy company dedicated to improving the management of hematuria patients and the early detection of bladder cancer, announced the launch of its laboratory-developed AssureMDx™ test.

Drug Discovery & Development | 06/05/2024 | By Manvi |  658

Lupin Introduces Rymti Biosimilar Etanercept in Canada

Lupin Ltd. has developed Rymti, Lupin’s first biosimilar in Canada, through its partner Sandoz Canada (Sandoz).

Drug Discovery & Development | 06/05/2024 | By Aishwarya |  592

Bespak Partners with H and T Presspart to Boost Transition to Low GWP Propellants in pMDIs

Bespak has teamed up with H&T Presspart to accelerate the industry’s transition from existing pressurised Metered Dose Inhaler (pMDI) formulations to more climate-friendly alternatives utilising low global warming potential (GWP) propellants.

Drug Discovery & Development | 04/05/2024 | By Aishwarya |  455

Dr. Reddys Laboratories Unveils Broad-Spectrum Antibiotics in USA

Dr. Reddy’s Laboratories Ltd. has introduced Doxycycline Capsules, 40 mg in the US market.

Drug Discovery & Development | 04/05/2024 | By Aishwarya |  1039

ProPharma and PBL Develop Cell and Gene Therapy Manufacturing Device

ProPharma has announced its collaboration with PBL and have jointly developed an enclosed, fully automated cell factory device, the Cell Factory Box (CF Box).

Drug Discovery & Development | 04/05/2024 | By Aishwarya |  530

Astellas Signs License Deal with Poseida to Develop Novel Allogeneic Cell Therapies

Astellas Pharma Inc. has announced that Xyphos Biosciences, Inc., a wholly owned subsidiary of Astellas and Poseida have signed a research collaboration and license agreement to develop novel convertibleCAR programs by combining the innovative cell therapy platforms from each of the companies.

Drug Discovery & Development | 03/05/2024 | By Aishwarya |  429